Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
$750,000
HHS-NIH11
POSTED: 10/22/2024
UPDATED: 10/22/2024
DUE: 10/20/2027
This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potent...
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
HHS-NIH11
POSTED: 10/18/2024
UPDATED: 10/18/2024
DUE: 10/15/2027
The NIDCD Early Career Research (ECR) Award (R21) is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. It cannot be us...
NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)
HHS-NIH11
POSTED: 10/18/2024
UPDATED: 10/18/2024
DUE: 01/07/2026
This notice of funding opportunity (NOFO) supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports differen...
Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial Optional)
HHS-NIH11
POSTED: 10/17/2024
UPDATED: 10/17/2024
DUE: 11/16/2025
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications focused on the neurological and/or mental health-related manifestations of infection-associated chronic illnesses, i...
Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional)
HHS-NIH11
POSTED: 10/17/2024
UPDATED: 10/17/2024
DUE: 11/05/2025
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications focused on the neurological and/or mental health-related manifestations of infection-associated chronic illnesses, i...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 10/15/2024
DUE: 10/14/2026
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications to support the validation of molecular/cellular/imaging markers (referred to as "markers" or...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 10/15/2024
DUE: 10/14/2026
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate the adoption and validation of molecular/cellular/imaging markers (referred to as "markers"...
Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 03/31/2025
DUE: 07/14/2026
This notice of funding opportunity (NOFO), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an investi...
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 10/15/2024
DUE: 12/03/2026
This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 10/15/2024
DUE: 12/03/2026
This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, ...